Lv31
370 积分 2022-10-02 加入
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
4小时前
已完结
儿童腺样体肥大临床诊治管理专家共识
8天前
已完结
An international consensus on the use of asthma biologics in pregnancy
27天前
已完结
Profiles of Cough and Associated Risk Factors in Nonhospitalized Individuals With SARS-CoV-2 Omicron Variant Infection: Cross-Sectional Online Survey in China
28天前
已完结
Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry
1个月前
已完结
The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
1个月前
已完结
The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
1个月前
已完结
我国>14岁重症哮喘患者的临床特征和患病危险因素
1个月前
已完结
Real-world effectiveness of mepolizumab in asthma: a systematic review and meta-analysi
1个月前
已完结
Long-term safety of mepolizumab for up to ∼10 years in patients with severe asthma: open-label extension study
1个月前
已完结
皖公网安备34019202002308
